The synthesis and hit-to-lead SAR development of a pyrazolo [1, 5-a] pyrimidine hit 4 is described leading to a series of potent, selective CHK1 inhibitors such as compound 17r. In the Letter, the further utility of the pyrazolo [1, 5-a] pyrimidine template for the development of potent, selective kinase inhibitors is detailed.